In general, no differences were observed in subgroup analyses of sex, smoking status, ECOG performance−status score, pathological stage, histologic features, PD-L1 tumor proportion score, region and planned neoadjuvant platinum agent (Table 4; Supplementary Figures 5, 6). Here, CD274 is linked to neoplasm.